UK committee takes close look at science and innovation investment:
This article was originally published in Clinica
Executive Summary
The UK's parliamentary committee on science and technology (STC) will later this month interview the science and innovation minister, Ian Pearson, and Professor Sir Keith O'Nions, director general of science and innovation at the newly-created Department for Innovation, Universities and Skills. The oral evidence session, which takes place on October 23 in Westminster, is part of an inquiry into the Science and Innovation Investment Framework 2004-2014, more specifically in reference to its 2007 annual report, published last July.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.